// App-Quantinova.ai

BSH19‐OR‐017 : Preventing and repairing myeloma bone disease by combining zoledronic acid with TGFβ inhibition therapy

Researchers

Presenter

  • J. Paton-Hough

Principal Investigators

  • M. Lawson

  • A. Chantry

Medical Centers

  • Dept of Oncology and Metabolism

  • Department of Oncology & Metabolism, University of Sheffield, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Zoledronic acid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved